Raab & Moskowitz Asset Management LLC Novo Nordisk A S Transaction History

Raab & Moskowitz Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$49.46 - $64.78 $12,365 - $16,195	-250 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$49.86 - $58.26 $12,465 - $14,565	250 New	250 $14,000
Q4 2018 Feb 04, 2019	SELL	$41.54 - $47.25 $10,385 - $11,812	-250 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $11,690 - $12,810	250 New	250 $11,000

1,952

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $225B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Raab & Moskowitz Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Raab & Moskowitz Asset Management LLC with notifications on news.